Glioblastoma is one of the most enigmatic and difficult-to-treat tumor types. Patients with the most common form of this brain cancer, IDH-wildtype glioblastoma, have a median survival of only 14.6 months, a number that has barely budged for decades. Two new studies seek to understand the disease more fully at the molecular level, with the …
RNA sequencing reveals glioblastoma heterogeneity and treatment resistance mechanisms
Share.
